Cabaletta Bio, Inc.

CABA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K May 14, 2026 8-K
8-K May 14, 2026 8-K
8-K May 4, 2026 8-K
424B5 May 4, 2026 424B5
8-K May 4, 2026 8-K
ARS Apr 28, 2026 ARS
DEFA14A Apr 28, 2026 DEFA14A
DEF 14A Apr 28, 2026 DEF 14A
8-K Apr 20, 2026 8-K
PRE 14A Apr 17, 2026 PRE 14A
S-8 Mar 23, 2026 S-8
10-K Mar 23, 2026 10-K
8-K Mar 23, 2026 8-K
4 Mar 2, 2026 4
4 Mar 2, 2026 4
4 Mar 2, 2026 4
4 Mar 2, 2026 4
4 Mar 2, 2026 4
4 Mar 2, 2026 4
SCHEDULE 13G Feb 18, 2026
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 17, 2026
4 Jan 21, 2026 4
4 Jan 21, 2026 4
← Newer Page 2 of 18 · 446 filings Older →